Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by mutant isoforms of p53

John Foley, John J. Wysolmerski, Arthur E. Broadus, William M. Philbrick

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Parathyroid hormone-related protein (PTHrP) is a normal secretory product of a variety of squamous epithelia, including epidermal keratinocytes. Only a subset of squamous carcinomas, however, express the gene at levels sufficient to cause humoral hypercalcemia. In the present study, comparison of PTHrP expression levels with p53 functional status in a series of squamous carcinoma lines has revealed an association between expression of specific mutant isoforms of p53 and very low levels of PTHrP mRNA. Evaluation of p53 isoforms with mutations in codons 248 and 273 showed them to be capable of repressing PTHrP gene expression in a high-expressing, p53-negative squamous line by approximately 50%. Conversely, inactivation of an endogenous mutant p53 with E1B proteins resulted in an increase in PTHrP expression in a low-expressing cell line. Subsequent analysis of promoter- specific PTHrP transcripts in a p53-negative squamous line transfected with mutant p53 isoforms suggested that down-regulation occurred primarily at the two TATA-based promoters. Direct testing of a murine PTHrP reporter construct in transient transfection assays confirmed the capacity of the 248 and 273 mutants to repress this TATA-based promoter, although only about half as effectively as wild-type p53.

Original languageEnglish (US)
Pages (from-to)4056-4062
Number of pages7
JournalCancer Research
Volume56
Issue number17
StatePublished - Sep 1 1996
Externally publishedYes

Fingerprint

Parathyroid Hormone-Related Protein
Squamous Cell Carcinoma
Protein Isoforms
Gene Expression
Hypercalcemia
Keratinocytes
Codon
Transfection
Down-Regulation
Epithelium
Cell Line
Messenger RNA
Mutation
Genes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by mutant isoforms of p53. / Foley, John; Wysolmerski, John J.; Broadus, Arthur E.; Philbrick, William M.

In: Cancer Research, Vol. 56, No. 17, 01.09.1996, p. 4056-4062.

Research output: Contribution to journalArticle

Foley, John ; Wysolmerski, John J. ; Broadus, Arthur E. ; Philbrick, William M. / Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by mutant isoforms of p53. In: Cancer Research. 1996 ; Vol. 56, No. 17. pp. 4056-4062.
@article{b9bb187f06dd4cc8b309cc04d2791f9a,
title = "Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by mutant isoforms of p53",
abstract = "Parathyroid hormone-related protein (PTHrP) is a normal secretory product of a variety of squamous epithelia, including epidermal keratinocytes. Only a subset of squamous carcinomas, however, express the gene at levels sufficient to cause humoral hypercalcemia. In the present study, comparison of PTHrP expression levels with p53 functional status in a series of squamous carcinoma lines has revealed an association between expression of specific mutant isoforms of p53 and very low levels of PTHrP mRNA. Evaluation of p53 isoforms with mutations in codons 248 and 273 showed them to be capable of repressing PTHrP gene expression in a high-expressing, p53-negative squamous line by approximately 50{\%}. Conversely, inactivation of an endogenous mutant p53 with E1B proteins resulted in an increase in PTHrP expression in a low-expressing cell line. Subsequent analysis of promoter- specific PTHrP transcripts in a p53-negative squamous line transfected with mutant p53 isoforms suggested that down-regulation occurred primarily at the two TATA-based promoters. Direct testing of a murine PTHrP reporter construct in transient transfection assays confirmed the capacity of the 248 and 273 mutants to repress this TATA-based promoter, although only about half as effectively as wild-type p53.",
author = "John Foley and Wysolmerski, {John J.} and Broadus, {Arthur E.} and Philbrick, {William M.}",
year = "1996",
month = "9",
day = "1",
language = "English (US)",
volume = "56",
pages = "4056--4062",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by mutant isoforms of p53

AU - Foley, John

AU - Wysolmerski, John J.

AU - Broadus, Arthur E.

AU - Philbrick, William M.

PY - 1996/9/1

Y1 - 1996/9/1

N2 - Parathyroid hormone-related protein (PTHrP) is a normal secretory product of a variety of squamous epithelia, including epidermal keratinocytes. Only a subset of squamous carcinomas, however, express the gene at levels sufficient to cause humoral hypercalcemia. In the present study, comparison of PTHrP expression levels with p53 functional status in a series of squamous carcinoma lines has revealed an association between expression of specific mutant isoforms of p53 and very low levels of PTHrP mRNA. Evaluation of p53 isoforms with mutations in codons 248 and 273 showed them to be capable of repressing PTHrP gene expression in a high-expressing, p53-negative squamous line by approximately 50%. Conversely, inactivation of an endogenous mutant p53 with E1B proteins resulted in an increase in PTHrP expression in a low-expressing cell line. Subsequent analysis of promoter- specific PTHrP transcripts in a p53-negative squamous line transfected with mutant p53 isoforms suggested that down-regulation occurred primarily at the two TATA-based promoters. Direct testing of a murine PTHrP reporter construct in transient transfection assays confirmed the capacity of the 248 and 273 mutants to repress this TATA-based promoter, although only about half as effectively as wild-type p53.

AB - Parathyroid hormone-related protein (PTHrP) is a normal secretory product of a variety of squamous epithelia, including epidermal keratinocytes. Only a subset of squamous carcinomas, however, express the gene at levels sufficient to cause humoral hypercalcemia. In the present study, comparison of PTHrP expression levels with p53 functional status in a series of squamous carcinoma lines has revealed an association between expression of specific mutant isoforms of p53 and very low levels of PTHrP mRNA. Evaluation of p53 isoforms with mutations in codons 248 and 273 showed them to be capable of repressing PTHrP gene expression in a high-expressing, p53-negative squamous line by approximately 50%. Conversely, inactivation of an endogenous mutant p53 with E1B proteins resulted in an increase in PTHrP expression in a low-expressing cell line. Subsequent analysis of promoter- specific PTHrP transcripts in a p53-negative squamous line transfected with mutant p53 isoforms suggested that down-regulation occurred primarily at the two TATA-based promoters. Direct testing of a murine PTHrP reporter construct in transient transfection assays confirmed the capacity of the 248 and 273 mutants to repress this TATA-based promoter, although only about half as effectively as wild-type p53.

UR - http://www.scopus.com/inward/record.url?scp=0029817937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029817937&partnerID=8YFLogxK

M3 - Article

C2 - 8752179

AN - SCOPUS:0029817937

VL - 56

SP - 4056

EP - 4062

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 17

ER -